1results about How to "Confirm the accuracy" patented technology

The present application belongs to the technical field of molecular medicine, and relates to a probe, a marker combination and a prediction method for non-invasive risk grading of neuroblastoma. The probe UUU-DZ-tFNA can detect UDG in vitro, cells, living bodies and plasma exosomes, and it is proved that UDG in plasma exosomes is closely related to the risk grading of NB. The plasma exosomes of NB patients are collected MYCN Whether to amplify, whether the tumor is metastatic, neuron-specific enolase content, lactate dehydrogenase content and plasma exosome UDG content are integrated, and a NB non-invasive risk grading prediction model is established through a machine learning algorithm. The optimal risk grading model is a neural network model. The area under the receiver operating characteristic curve of the combined model is improved by 5.2% compared with the optimal prediction result of the combined prediction model of the single clinical index, and the sensitivity and specificity are significantly improved. The present application has key clinical values for accurate grading of NB children, individualized treatment plan formulation and efficacy monitoring.